Portfolio Design Labs’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Portfolio Design Labs's PFE Position: Q2 2026 in Review
Portfolio Design Labs increased its Pfizer (PFE) stake by 7.6% in Q2 2026, buying an estimated $93.3K and bringing the position to 50,289 shares worth $1.21M. The position accounts for 0.2% of the portfolio, ranked #98.
Portfolio Design Labs first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.42M in Q3 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Portfolio Design Labs held 50,289 shares of Pfizer worth $1.21M as of Q2 2026.
- Portfolio Design Labs bought 3,568 Pfizer shares in Q2 2026, an estimated $93.3K.
- Pfizer made up 0.2% of Portfolio Design Labs's portfolio in Q2 2026, its #98 holding.
- Portfolio Design Labs first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
- Portfolio Design Labs's Pfizer position peaked at $1.42M in Q3 2025.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.